PK Study of IV Formulation of GW856553

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2010

Primary Completion Date

April 15, 2010

Study Completion Date

April 15, 2010

Conditions

Cardiovascular Disease

Interventions

DRUG

losmapimod 1 mg

IV infusion

DRUG

losmapimod

IV infusion (dose to be determined based on PK from first dose)

DRUG

losmapimod 15 mg

oral, two 7.5 mg tablets

Trial Locations (1)

GSK Investigational Site, Cambridge